Jump to Navigation
Trends and Sentiments
Comments and Analysis
Volunteers jump at chance to join trial of Canadian-made...
Striking Photos From The Iditarod Show Just How Gnarly...
The Coming Dissolution of the EU
US-led aircraft pound IS group with 23 air strikes
Here's How UNC's Massive Fake-Class Scandal...
NewsWatch: Buy Apple and sell Google if you can own only...
How Will GLD Respond After QE3 Ends?
High Grade Review And Outlook For 3rd Quarter
Luis Suarez starts for Barcelona in El Clasico
New York Fed's Conference Evokes Violent Thoughts...
Are These 10 Sick Healthcare Companies Terminally Ill?
14 Oversold Stocks Trading Near Lows but Being Bought Up by the Smart Money
Top Biotech Picks of High Alpha Funds
5 Healthcare Stocks of Interest This Week
10 Stocks With Bullish Momentum Backed By Strong Top Line Growth
10 Biotech Stocks Being Dumped By Big Money Managers
3 Highly Shorted Biotech Stocks With Strong Institutional Selling
Focus On Entereg; Reiterating Buy On Adolor
Healthcor Management's Latest New And Increased Positions
5 Highly Shorted Healthcare Stocks Being Sold By Smart Money
18 Healthcare Stocks Undervalued By Target Price
10 Biotech Stocks Trading At The Deepest Discounts To Target Price
Analysis Of Institutional 5% Ownership Filings On Friday
Small-Cap, Biotech-Focused Hedge Fund BVF's Top Q3 Picks
Nektar Therapeutics: Often Forgotten, But Worth A Look
12 Healthcare Stocks With Bearish Short Trends
Buy Biotech In Phase II For The Best Upside
What's It Going To Take To Get Salix Cheap?
The Age Of Personalized Medicine Has Arrived
20 Biotech Stocks Being Bought Up By Hedge Funds
A Small-Cap Biotech Stocks Being Accumulated By The World's Largest Money Managers
Long Undervalued, Is Alkermes Still A Bargain?
Why The Markets Continue To Coalesce Around New Approaches To Treating Cancer
5 Hedge Fund Biotech Stock Picks With Significant Short Covering
The Dollar: More of the Same
New York Fed's Conference Evokes Violent...
EUR/GBP: 1.2698 USD/EUR: 1.267 JPY/USD: 108.145
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions